$RGLS break out pattern / low volume - swing idea
Updated
Possible break out soon.
Low Risk / Reward to 50 dma
Reason:
Stair stepping on daily making higher lows
Low volume
Indicator: RSI is at 45 and has been increasing (not overbought yet)
MACD still in negative so this might spike soon.
Recent offering in 2018 had created a sell off and currently accumulation has been steadily moving the price higher.
Higher Lows
Other reasons that looks promising:
New: Patent approval
finance.yahoo.com/news/regulus-announces-preliminary-results-planned-210500664.html
Insider buyers
finance.yahoo.com/news/know-regulus-therapeutics-inc-nasdaq-145651204.html
Trade Idea:
Swing: buy near 1.10-1.13 or within the black dash line
Daytrade: wait for break of 1.23 or safer 1.25 (watch for news or volume to enter as this has low volume)
Remember to:
Trade with a plan, set your stop loss, take profits at any spike above 8% (rinse and repeat)
Low Risk / Reward to 50 dma
Reason:
Stair stepping on daily making higher lows
Low volume
Indicator: RSI is at 45 and has been increasing (not overbought yet)
MACD still in negative so this might spike soon.
Recent offering in 2018 had created a sell off and currently accumulation has been steadily moving the price higher.
Higher Lows
Other reasons that looks promising:
New: Patent approval
finance.yahoo.com/news/regulus-announces-preliminary-results-planned-210500664.html
Insider buyers
finance.yahoo.com/news/know-regulus-therapeutics-inc-nasdaq-145651204.html
Trade Idea:
Swing: buy near 1.10-1.13 or within the black dash line
Daytrade: wait for break of 1.23 or safer 1.25 (watch for news or volume to enter as this has low volume)
Remember to:
Trade with a plan, set your stop loss, take profits at any spike above 8% (rinse and repeat)
Order cancelled
failed to hold within the black dotted line. No entry.Note
The market is perking up SPY / IBBRGLS has potential to pop after recent RS so this will be on alert if it goes back to buy zone.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.